Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $110.7200 (0.61%) ($106.1600 - $115.4500) on Thu. Jan. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.79% (three month average) | RSI | 30 | Latest Price | $110.7200(0.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -3.9% a day on average for past five trading days. | Weekly Trend | LGND declines -5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(55%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.895% in a week (0% probabilities). VXX(-15%) TLT(-15%) VIXM(-10%) UUP(-10%) GDXJ(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.895% (StdDev 3.79%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
Resistance Level | $132.76 | 5 Day Moving Average | $123.12(-10.07%) | 10 Day Moving Average | $130.8(-15.35%) | 20 Day Moving Average | $132.76(-16.6%) | To recent high | -45.5% | To recent low | 0.6% | Market Cap | $1.779b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |